32 Results

People

  1. Lacouture
    Lacouture
  2. Marghoob
    Marghoob
  3. Khakoo
    Khakoo
  4. Markova
    Markova
  5. Dunkel
    Dunkel
  6. Ponce
    Ponce
  7. Dusza
    Dusza
  8. Haque
    Haque
  9. Prockop
    Prockop
  10. Perales
    Perales

Groups

  1. Department of Medicine (32)
  2. Dermatology Service (32)
  3. Dermatology (32)
  4. Division of Subspecialty Medicine (32)
  5. Pediatrics, Department of (32)
  6. Survivorship Research (32)
  7. Neuro-Oncology Service (19)
  8. Center for Hematologic Malignancies (16)
  9. Hematologic Malignancies, Division of (12)
  10. Stem Cell Transplantation and Cellular Therapy Service (10)
  1. "Division of Subspecialty Medicine "
  2. "Department of Medicine"
  3. "Dermatology"
  4. "Survivorship Research"
  5. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (15)
  3. Book Section (1)
Groups
  1. Department of Medicine (32)
  2. Dermatology (32)
  3. Dermatology Service (32)
  4. Division of Subspecialty Medicine (32)
  5. Pediatrics, Department of (32)
  6. Survivorship Research (32)

More Groups

People
  1. Mario Lacouture (13)
  2. Ashfaq Marghoob (12)
  3. Yasmin Khakoo (11)
  4. Alina Markova (10)
  5. Doris Ponce (8)
  6. Ira Dunkel (8)

More People

Years
  1. 2023 (3)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (4)
  6. 2018 (3)

More Years

Publications
  1. Neuro-Oncology (6)
  2. Transplantation and Cellular Therapy (4)
  3. Journal of Clinical Oncology (3)
  4. Pediatric Dermatology (3)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Blood (2)

More Publications

Publishers
  1. Oxford University Press (8)
  2. Elsevier Inc. (6)
  3. American Society of Clinical Oncology (3)
  4. American Society of Hematology (3)
  5. Blackwell Scientific Publications (3)
  6. Nature Publishing Group (2)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial
    Meeting Abstract

    Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
    Meeting Abstract

    Gu, S.; Dusza, S. W.; Dunkel, I. J.; Drilon, A. E.; Lacouture, M. E.; Markova, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neurocutaneous melanocytosis-associated hydrocephalus: The MSK experience from 2001-2022
    Meeting Abstract

    Rodriguez, S.; Sener, U.; Elmore, K.; Haque, S.; Suser, S.; Greenfield, J.; Donzelli, M.; DePass, C.; Pugh, J.; Porter, J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-time reflectance confocal microscopy of cutaneous graft-versus-host disease correlates with histopathology
    Journal Article

    Reingold, R. E.; Monnier, J.; Ardigò, M.; Stoll, J. R.; Pena, M. C.; Nanda, J. K.; Dusza, S. W.; Ruiz, J. D.; Flynn, L.; Afrin, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle- and comparator-controlled trial on safety and efficacy of a topical inhibitor of janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non- sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Pan, A.; Dusza, S.; Chowdhury, A.; Kukoyi, O.; Perales, M. A.; Lacouture, M.; Prockop, S.; Ponce, D. M.
    Blood (2021)

    Fulltext@MSK | Save
  • Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding
    Journal Article

    Sener, U.; Elmore, K.; Jayaseelan, K.; Porter, J.; Marghoob, A.; Rosenblum, M. K.; Haque, S.; Khakoo, Y.
    Pediatric Dermatology (2021)

    Fulltext@MSK | Save